Patent · US Active

Anti-GITR antibodies and uses thereof

US11414494B2 · kind B2 · utility

2Cited by

18References

26Claims

0Family size

Assignee

REGENERON PHARMACEUTICALS, INC. · US

Inventors

Frank Delfino · Poughquag, US
Dimitris Skokos · New York, US
Bei Wang · Hastings-on-Hudson, US

Key dates

Filing date	Jun 26, 2020
Grant date	Aug 16, 2022
Priority date	—
Expiry date	Oct 10, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are antibodies, and antigen-binding fragments thereof that specifically bind glucocorticoid-induced tumor necrosis factor receptor (GITR) and methods of using the same, including, e.g., methods of treatment using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.